^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Mvasi (bevacizumab-awwb)

i
Other names: ABP 215
Company:
AbbVie, Amgen, Daiichi Sankyo
Drug class:
VEGF-A inhibitor
Related drugs: